Group structure
20 companies in 7 countries
Loading…
20 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 114
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abirateron MSN 250 mg filmom obložene tableteFilmom obložena tableta | Abiraterone | Croatia | Authorised | 2024 |
| Abirateron MSN 500 mg filmom obložene tableteFilmom obložena tableta | Abiraterone | Croatia | Marketed | 2024 |
| AZACITIDINE FOR INJECTION100 mg / vial · Powder For Suspension | Azacitidine | Canada | Authorised | |
| Bosutinib MSN 100 mg filmom obložene tableteFilmom obložena tableta | Bosutinib | Croatia | Not marketed | 2025 |
| Bosutinib MSN 400 mg filmom obložene tableteFilmom obložena tableta | Bosutinib | Croatia | Not marketed | 2025 |
| Bosutinib MSN 500 mg filmom obložene tableteFilmom obložena tableta | Bosutinib | Croatia | Not marketed | 2025 |
| BRIVARACETAM10mg/ml · Solution | Brivaracetam | United States | Marketed | 2026 |
| Clizay 100 mg filmom obložene tableteFilmom obložena tableta | Brivaracetam | Croatia | Not marketed | 2026 |
| Clizay 25 mg filmom obložene tableteFilmom obložena tableta | Brivaracetam | Croatia | Not marketed | 2026 |
| Clizay 50 mg filmom obložene tableteFilmom obložena tableta | Brivaracetam | Croatia | Not marketed | 2026 |
| DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE10mg; 5mg base · Tablet | Dapagliflozin, Saxagliptin | United States | Marketed | 2026 |
| Daplemsen 10 mg filmom obložene tableteFilmom obložena tableta | Dapagliflozin | Croatia | Not marketed | 2026 |
| Daplemsen 5 mg filmom obložene tableteFilmom obložena tableta | Dapagliflozin | Croatia | Not marketed | 2026 |
| DEXRAZOXANE HYDROCHLORIDE250mg base/vial | 500mg base/vial · Injectable | Dexrazoxane | United States | Marketed | 2004 |
| Dimetilfumarat MSN 120 mg tvrde želučanootporne kapsuleŽelučanootporna kapsula, tvrda | Dimethyl | Croatia | Marketed | 2024 |
| Dimetilfumarat MSN 240 mg tvrde želučanootporne kapsuleŽelučanootporna kapsula, tvrda | Dimethyl | Croatia | Marketed | 2024 |
| Eltrombopag MSN 25 mg filmom obložene tableteFilmom obložena tableta | Eltrombopag | Croatia | Not marketed | 2025 |
| Eltrombopag MSN 50 mg filmom obložene tableteFilmom obložena tableta | Eltrombopag | Croatia | Not marketed | 2025 |
| Eltrombopag MSN 75 mg filmom obložene tableteFilmom obložena tableta | Eltrombopag | Croatia | Not marketed | 2025 |
| Eplerenon MSN 25 mg filmom obložene tableteFilmom obložena tableta | Eplerenone | Croatia | Marketed | 2026 |
| Eplerenon MSN 50 mg filmom obložene tableteFilmom obložena tableta | Eplerenone | Croatia | Marketed | 2026 |
| IRBESARTAN150mg | 300mg | 75mg · Tablet | Irbesartan | United States | Marketed | 2012 |
| Isovurex 10 mg tableteTableta | Ezetimiba | Croatia | Authorised | 2024 |
| IVABRADINE HYDROCHLORIDE5mg base | 7.5mg base · Tablet | Ivabradine | United States | Marketed | 2021 |
| Jesoxade 10 mg filmom obložene tableteFilmom obložena tableta | Macitentan | Croatia | Marketed | 2026 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Croatia | 56 | 56 | 0 | CompaniesAll medicines |
| Saudi Arabia | 29 | 29 | 0 | CompaniesAll medicines |
| United States | 26 | 13 | 13 | CompaniesAll medicines |
| Colombia | 2 | 0 | 2 | CompaniesAll medicines |
| Canada | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Malaysia, Serbia, Singapore, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros, dataset spzp-dfuc, rowsUpdatedAt 1792152828, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Report an error or request removalCorrections from the company itself are welcome.
Keep MSN’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callInstituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65fc6f1ba855cc196a8ba/New_Manufacturing_and_Wholesale_Dealer_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:18.644817+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA published licence history
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Well-known pharmaceutical groups, each with all its companies.